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All mammalian cells are equipped with large numbers of sensors for protection
from various sorts of invaders, who, in turn, are equipped with molecules containing
pathogen-associated molecular patterns (PAMPs). Once these sensors recognize non-self
antigens containing PAMPs, various physiological responses including inflammation are
induced to eliminate the pathogens. However, the host sometimes suffers from chronic
infection or continuous injuries, resulting in production of self-molecules containing
damage-associated molecular patterns (DAMPs). DAMPs are also responsible for the
elimination of pathogens, but promiscuous recognition of DAMPs through sensors against
PAMPs has been reported. Accumulation of DAMPs leads to massive inflammation and
continuous production of DAMPs; that is, a vicious circle leading to the development of
autoimmune disease. From a vaccinological point of view, the accurate recognition of both
PAMPs and DAMPs is important for vaccine immunogenicity, because vaccine adjuvants
are composed of several PAMPs and/or DAMPs, which are also associated with severe
adverse events after vaccination. Here, we review as the roles of PAMPs and DAMPs upon
infection with pathogens or inflammation, and the sensors responsible for recognizing
them, as well as their relationship with the development of autoimmune disease or the
immunogenicity of vaccines.
Keywords: PAMPs (pathogen-associated molecular patterns), DAMPs (damage-associated molecular patterns),
nucleic acids, metabolites, innate immunity, DNA sensors, uric acid, vaccine adjuvant
INTRODUCTION
Host cells are equipped with numerous types of receptors to
discriminate self from non-self. When cells are attacked by infec-
tious pathogens, host cellular receptors such as Toll-like receptors
(TLRs), nucleotide oligomerization domain (NOD)-like recep-
tors (NLRs), retinoic acid-inducible gene-I (RIG-I)-like receptors
(RLRs), C-type lectin receptors, and other non-classified recep-
tors recognize pathogen-associated molecular patterns (PAMPs),
small molecular motifs conserved amongst microbes. Through
the recognition of PAMP molecules, innate immune responses
are induced, and inflammatory cytokines are produced that aid
in the elimination of the pathogens. However, in some circum-
stances host inflammatory responses can cause host cell death
leading to tissue injury, and the release of host cellular com-
ponents to the extracellular environment. These cellular com-
ponents could be considered “messengers” for danger; they are
also known as “damage-associated molecular patterns” (DAMPs).
DAMPs include lipids, sugars, metabolites, and nucleic acids
such as RNA and DNA species. DAMPs are important for the
elimination of pathogens, but are also implicated in the devel-
opment of autoimmune disease and chronic inflammatory dis-
ease, and are used as adjuvants for vaccines. Interestingly, high
numbers of PAMP receptors also recognize endogenous DAMPs
and can augment inflammatory responses against pathogens,
whereas continuous inflammatory responses owing to impaired
regulation of inflammatory signaling results in chronic inflamma-
tory disease or autoimmune disease. Therefore, “bipolar sensors”
for both PAMPs and DAMPs appear to be the mostly responsi-
ble for dysregulated inflammation. Here, we describe the various
types of DAMPs and their receptors, with a special focus on
nucleic acids as DAMPs.
LIPID-RELATED DAMPs
LIPOPOLYSACCHARIDE (LPS)
A representative lipid for the induction of inflammatory
responses is LPS, a PAMP present in gram-negative bacte-
ria. Upon recognition by TLR4, LPS promotes the production
of various inflammatory cytokines following bacterial infection
(Table 1). However, Shi et al. reported that, TLR4 also rec-
ognizes endogenous fatty acids and can activate inflammatory
responses in adipocytes and macrophages (Shi et al., 2006).
In addition, TLR4-deficient mice developed reduced inflamma-
tory cytokine production in response to a high fat diet (Shi
et al., 2006). Previous studies have revealed that saturated fatty
acids are released from hypertrophied adipocytes in the pres-
ence of macrophages, and that released fatty acids are sensed by
macrophages in a TLR4-dependent manner, following excessive
production of inflammatory cytokines such as tumor necrosis
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Table 1 | Association of PAMP or DAMP sensors with autoimmune diseases.
Receptor PAMP DAMP Autoimmune disease
TLR1/TLR2 Lipopeptide Serum amyloid A protein Atherosclerosis, rheumatoid arthritis, Crohn’s disease
TLR4 LPS Fatty acid Obesity
Hyaluronic acid Rheumatoid arthritis, sarcoidosis, systemic sclerosis,
pancreatic cancer
NLRP3 Uric acid Uric acid Hyperuricemia, gout
ATP Unknown
RIG-I, MDA5, TLR7/8 Virus RNA Immunocomplex of snRNPs SLE
TLR9 Bacterial DNA Self-DNA-containing immune
complexes, histone
SLE
RAGE −/? HMGB1 SLE
DAI, IFI16, AIM2, H2B,
RNA pol III
Bacterial DNA, Virus DNA Self-DNA? SLE?
factor (TNF)-α (Suganami et al., 2007). Because the production
of pro-inflammatory or inflammatory cytokines is dysregulated
in obese adipose tissues, obesity can be thought of as a chronic
inflammatory disease caused by fatty acids acting as DAMP
molecules (Berg and Scherer, 2005).
SERUM AMYLOID A PROTEIN (SAA)
Some lipoproteins can also act as DAMP molecules. In 1982,
Hoffman and Benditt revealed that the treatment of mice with
LPS of Salmonella typhosa increased SAA levels (Hoffman and
Benditt, 1982). According to several studies, SAA functions in
cholesterol transport as well as in the production of proinflam-
matory cytokines, suggesting that SAA is a DAMP molecule
that responds to bacterial endotoxins (Banka et al., 1995; He
et al., 2003). In support of this, increased levels of SAA may
be closely related to various diseases such as atherosclerosis,
rheumatoid arthritis, and Crohn’s disease (Chambers et al., 1983,
1987; Malle and De Beer, 1996). SAA binds to two recep-
tors, TLR4 and TLR2, which also recognize bacterial PAMP
molecules such as triacyl lipopeptides (in cooperation with
TLR1), diacyl lipopeptides or lipoteichoic acids (together with
TLR6) (Schwandner et al., 1999; Takeuchi et al., 2001, 2002;
Cheng et al., 2008; Hiratsuka et al., 2008) (Table 1). Recently,
Loser et al. showed direct evidence for the local production
of the SAA molecules myeloid-related protein-8 (Mrp8) and
Mrp14, which induced autoreactive CD8+ T cells and sys-
temic autoimmunity through TLR4 signaling in mice (Loser
et al., 2010). Taken together, these findings suggest that TLR4
may be a key receptor in the discrimination of lipid PAMPs
from lipid DAMPs molecules, because promiscuous recogni-
tion of lipids via TLR4 unfortunately causes inflammatory dis-
ease. Although a consensus recognition structure for TLR4 has
not yet been identified, antagonists of TLR4 signaling by lipid-
DAMPs might be candidate drugs for the treatment of chronic
inflammatory disease.
SUGAR-RELATED DAMPs
Hyaluronic acid (HA) is a non-sulfated linear polysaccharide,
and a major component of the extracellular matrix. Weigel et al.
revealed that HA is induced and degraded during inflammatory
responses and that it functions in immune cell activation or new
blood vessel formation (Weigel et al., 1986). Interestingly, small
molecular weight HA (sHA), produced by the degradation of
HA during inflammation, can induce the maturation of den-
dritic cells (DCs) for pathogen elimination (Termeer et al., 2002).
Bone marrow-derived DCs from mice expressing non-functional
TLR4 could not be activated by sHA, while DCs from TLR2-
deficient mice retained the ability for sHA-mediated activation.
This suggests that sHA can act as a DAMP molecule signaling
through TLR4 to induce DCmaturation upon pathogen infection
(Termeer et al., 2002). Consistent with this, excessive sHA levels
appeared to be closely associated with inflammatory autoimmune
diseases such as rheumatoid arthritis, sarcoidosis, systemic sclero-
sis, and pancreatic cancer (Hallgren et al., 1985;Witter et al., 1987;
Sugahara et al., 2006; Yoshizaki et al., 2008) (Table 1).
METABOLITE-RELATED DAMPs
URIC ACID
Uric acid is a metabolite of purine nucleotides and free bases in
humans and other primates, and it functions as an antioxidant
to protect erythrocyte membranes from lipid oxidation (Kellogg
and Fridovich, 1977). However, it was previously shown that sol-
uble uric acid-induced inflammatory cytokines such as monocyte
chemoattractant protein-1 in rat vascular smooth muscle cells
(Kanellis et al., 2003). Shi et al. also reported that uric acid is
produced in ultraviolet-irradiated BALB/c 3T3 cells, and activates
DCs (Shi et al., 2003). In addition, high levels of uric acid in the
blood are associated with the development of hyperuricemia and
gout (Johnson et al., 2005), suggesting that it acts as a DAMP dur-
ing cell injury and can induce inflammatory responses that are
related to autoinflammatory diseases such as gout (Table 1).
Frontiers in Cellular and Infection Microbiology www.frontiersin.org January 2013 | Volume 2 | Article 168 | 2
Jounai et al. Immune sensors for nucleic acids
Receptors that recognize uric acid have been reported and
Liu-Bryan et al. revealed that TLR2, TLR4, and their adaptor
moleculeMyD88 are important for uric acid-mediated inflamma-
tion (Liu-Bryan et al., 2005). In contrast, the uric acid-mediated
activation of DCs was shown to be TLR4-independent, sug-
gesting the possible existence of other receptors that recognize
uric acid in addition to TLR2 and TLR4 (Shi et al., 2003).
To solve this question, Martinon et al. demonstrated that uric
acid could be sensed by another receptor, NOD-like recep-
tor family, pyrin domain-containing 3 (NLRP3), and induced
to produce interleukin (IL)-1β through caspase-1 activation
(Martinon et al., 2006). NLRP3 is a member of the NLR fam-
ily, and a component of the inflammasome, a platform that
induces IL-1β and IL-18 production. NLRP3 senses various types
of pathogen infections or irritants such as Candida albicans,
Legionella pneumophila, Listeria monocytogenes, Malaria hemo-
zoin, alum, silica, and asbestos as well as uric acid (Kanneganti
et al., 2006; Martinon et al., 2006; Dostert et al., 2008,
2009; Eisenbarth et al., 2008; Gross et al., 2009). Collectively,
these results revealed that NLRP3 is a promiscuous receptor
that senses PAMPs and DAMPs and can induce inflammatory
responses.
ADENOSINE TRIPHOSPHATE (ATP)
ATP is an essential purine base required for almost all physi-
cal responses such as glucose metabolism, muscle contraction,
biosynthesis, and molecular transfer. However, extracellular
ATP from injured cells or non-apoptotic cells also serves
as a danger signal through the activation of NLRP3 and
caspase-1 (Communi et al., 2000). Previous detailed research
has shown the importance of other ion channel molecules,
namely, P2X7 and pannexin-1, in inducing extracellular ATP-
mediated caspase-1 activation following IL-1β maturation
(Ferrari et al., 2006; Kanneganti et al., 2007). The formation
of the NLRP3 inflammasome requires an adaptor molecule,
apoptosis-associated speck-like protein containing a carboxy-
terminal caspase recruitment domain (ASC). ASC-deficient mice
cannot activate caspase-1 and thus do not produce mature
IL-1β following exposure to large amounts of ATP, suggest-
ing that ATP-mediated IL-1β production is dependent on the
NLRP3 inflammasome (Mariathasan et al., 2004). However,
although extracellular ATP has been suggested to act as a DAMP
molecule, there is no correlation between high amounts of
extracellular ATP acting as DAMPs in vitro and physiological
conditions in vivo. Eckle et al. suggested that most extracel-
lular ATP might be immediately hydrolyzed by ectonucleoti-
dases (Eckle et al., 2007). Taken together, investigation into
the roles of extracellular ATP in inducing pathological and
immune responses in vivo may provide important clues regard-
ing themechanism underlying inflammation induction byDAMP
molecule recognition or in the development of inflammatory
diseases.
NUCLEIC ACID-RELATED DAMPs
UNMETHYLATED CpGMOTIF AND GENOMIC DNA
As described above, uric acid and ATP are products of purine
metabolism. Nucleic acids such as adenine or guanine are also
purine metabolites. Nucleic acids exist in all organisms including
pathogens, and function as a store of genetic information for
protein translation and synthesis. Bacterial genomic DNA can
be recognized as a PAMP, as it contains unmethylated CpG
motifs whose frequency is higher in genomic DNA derived
from pathogens compared with that of vertebrates. The earli-
est research related to bacterial genomic DNA as PAMPs was
reported more than hundred years ago. Bruns et al. inves-
tigated heat-killed gram-negative or gram-positive bacteria as
an immunotherapeutic agent termed Coley’s toxin, for cancer
(Swain, 1895). Although LPS is a major factor in mediating
anti-tumor effects, other factors may be connected with its physi-
ological function, as gram-positive bacteria do not express LPS.
A hundred years on from the discovery of Coley’s toxin, sev-
eral studies have shown that bacterial DNA can activate nat-
ural killer (NK) cells or B cells, suggesting that the bacterial
genomic DNA in Coley’s toxin could contribute to its anti-
tumor activity by stimulating NK cells (Shimada et al., 1986;
Messina et al., 1991). Krieg et al. further revealed that bac-
terial genomic DNA contains unmethylated CpG motifs that
can stimulate B cells and NK cells, and induce inflammatory
cytokine production. Interestingly, methylated bacterial DNA
failed to stimulate immune cells, indicating that unmethylated
CpG motifs may act as PAMP molecules (Krieg et al., 1995;
Klinman et al., 1996). However, whether genomic DNA con-
taining methylated CpG motifs is incapable of innate immune
activation remains controversial. In 1962, Glasgow et al. reported
that ultraviolet-inactivated vaccinia virus, a DNA virus, resulted
in IFN production in mouse cells (Glasgow and Habel, 1962).
In addition, Suzuki et al. showed that viral DNA, vertebrate
DNA and bacterial DNA induced the upregulation of major
histocompatibility complex (MHC) class I expression and the
type I IFN-related activation of transcription factors such as
STAT3 in rat thyroid cells, suggesting that genomic DNA also
activates innate immune signaling in a CpG-motif-independent
manner (Suzuki et al., 1999). Interestingly, the structure of
DNA strongly affects DNA-mediated innate immune activation.
Double-stranded, right-handed B-form DNA, but not the left-
handed Z-form DNA, strongly induced type I IFN production.
Genomic DNA has a high content of B-form DNA, indicating
that it may also function as a PAMP or DAMP (Ishii et al.,
2006). Mitochondrial DNA has been also reported to function
as a DAMP molecule. Zhang et al. reported that cellular injury
caused the release of mitochondrial DNA, and induced systemic
inflammatory responses via p38 MAPK activation in a TLR9-
dependent manner. In addition, trauma patients had higher
amounts of mitochondrial DNA than did healthy volunteers, sug-
gesting that mitochondrial DNA could be considered a marker
of inflammatory disease (Zhang et al., 2010). When the clear-
ance of mitochondrial DNA by autophagy was inhibited, IL-1β
production was augmented via the NLRP3 inflammasome to acti-
vate caspase-1, indicating that the amount of mitochondrial DNA
DAMP activity is regulated by autophagy to suppress erroneous
activation of innate immunity (Nakahira et al., 2011). Indeed, it
was revealed that autophagy negatively regulates RNA-mediated
type I IFN production, possibly to maintain cellular homeostasis
(Jounai et al., 2007).
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CORRELATION BETWEEN AUTOIMMUNE DISEASE AND DNA DAMPs
Both DNA and RNA can function as PAMPs and DAMPs, and are
closely connected with inflammatory responses and the develop-
ment of inflammatory disease. Direct evidence for DNA acting
as a DAMP was shown using DNase-deficient mice. DNase I is
present in extracellular compartments such as the sera and urine,
and functions to degrade single-stranded DNA (ssDNA), double-
stranded DNA (dsDNA), or chromatin, which are released from
damaged or necrotic cells. Napirei et al. constructed DNase I-
deficient mice, and reported that they presented with the classical
symptoms of systemic lupus erythematosus (SLE) and glomeru-
lonephritis (Napirei et al., 2000). In addition, DNase II deficient
mice showed a similar phenotype to DNase I knockout mice.
DNase II in the lysosomes of macrophages degrades DNA from
apoptotic cells or nuclear genome DNA from liver erythrob-
lasts. Interestingly, DNase II-deficient mice presented with lethal
anemia owing to high levels of type I IFN production, caused
by the accumulation of non-degraded genomic DNA in liver
macrophages (Yoshida et al., 2005). In support of this, DNase II
and IFNRa/b double knockout mice showed a non-lethal pheno-
type, but developed rheumatoid arthritis-like symptoms (Kawane
et al., 2006), which could be attenuated by anti-TNF-α anti-
body treatment. This suggested that the accumulation of genomic
DNA in macrophages induced inflammatory cytokines, includ-
ing type I IFNs and TNF-α, and the synergistic action of these
inflammatory cytokines resulted in lethal systemic inflammation
(Kawane et al., 2006). Furthermore, studies on DNase III, also
known as TREX1, also revealed that DNA could function as a
DAMP. TREX1 is the major 3′ → 5′ DNA exonuclease for DNA
editing in DNA replication or DNA repair. Morita et al. showed
that trex1-deficient mice had a reduced survival rate owing to
high susceptibility to inflammatory myocarditis, although null
mice showed no spontaneous mutations or tumor development
(Morita et al., 2004). To explain why trex1-deficient mice develop
inflammatory myocarditis, Crow et al. demonstrated that the
mutation in the trex1 gene that abolished TREX1 enzyme activ-
ity was responsible for the development of Aicardi-Goutieres
syndrome (AGS), a severe neurological brain disease with high
levels of IFN-α in cerebrospinal fluid or serum, suggesting that
TREX1 is a suppressor of DNA DAMP-mediated inflammatory
responses (Crow et al., 2006). Furthermore, it was previously
shown that the abolishment of interferon regulatory factor 3
(IRF3) or IFN-α receptor 1 ameliorated the AGS symptoms in
trex1-deficient mice (Stetson et al., 2008). Collectively, these find-
ings suggest that the dysregulation of self-DNA results in severe
inflammatory responses such as high levels of type I IFNs leading
to autoinflammatory disease.
NUCLEIC ACID SENSORS
Host cells are equipped with numerous types of receptors to
recognize nucleic acids as PAMPs or DAMPs. These recep-
tors function to protect the host from pathogen infection, but
may also cause autoimmune disorders by inducing the con-
stitutive activation of inflammatory responses (Figure 1). In
this section, we introduce the well-characterized nucleic acid
sensors.
TLRs
A large body of research exists demonstrating the TLR-mediated
sensing of nucleic acids. TLR3 preferentially senses double-
stranded RNA (dsRNA) species, which can originate from some
viruses, and TLR3 is associated with induction of innate immu-
nity in response to infection with West Nile virus, respiratory syn-
cytial virus, and encephalomyocarditis virus (Wang et al., 2004;
Groskreutz et al., 2006; Hardarson et al., 2007) (Figure 2). In
addition, artificial dsRNA, poly (I:C), has been well-characterized
as a ligand for TLR3. Although pathogen-related dsRNAs act as
PAMPs, Kariko et al. reported that host messenger RNA could be
sensed by TLR3 to induce inflammatory responses (Kariko et al.,
2004). RNA released from necrotic cells can also elicit type I IFN
production, suggesting that host RNAmight function as a DAMP
upon cellular injury (Kariko et al., 2004).
TLR7 and TLR8 recognize single-stranded RNA (ssRNA),
and induce anti-viral innate immune responses against influenza
virus or vesicular stomatitis virus (Lund et al., 2004) (Figure 2).
Regardless of their common ligands, the cellular and tissue distri-
bution of TLR7 expression is in contrast to that of TLR8. Human
TLR7 is highly expressed in plasmacytoid DCs that preferentially
induce type I IFN production, and is expressed at lower levels in
myeloid cells. Conversely, the level of TLR8 expression is higher in
monocytes and in monocyte-derived DCs than in plasmacytoid
DCs (Hornung et al., 2002). Furthermore, mouse TLR8 did not
respond to ssRNA, but human TLR8 did, suggesting that TLR8
might be inactivated in mice, although several papers have also
linked mouse TLR8 with neuronal apoptosis and autoimmunity
(Heil et al., 2004; Gorden et al., 2006; Ma et al., 2006).
In addition to the recognition of PAMPs, Vollmer et al.
revealed that promiscuous recognition through TLR7 or TLR8
causes the development of SLE with high levels of type I
IFNs and TNF-α production (Vollmer et al., 2005). Because
the sera from SLE patients contains high levels of autoantibod-
ies against self-antigens, such as small nuclear ribonucleopro-
tein particles (snRNPs) including ssRNA, TLR7, or TLR8 could
recognize the immunocomplex of snRNPs with autoantibodies
thorough Fc receptor-mediated internalization (Vollmer et al.,
2005). Interestingly, TLR7 appears to be a specific sensor for
the induction of type I IFN production from plasmacytoid DCs,
whereas TLR8 is specific for TNF-α production from monocytes
in SLE patients, suggesting that plasmacytoidDCs andmonocytes
collaborate to develop inflammatory responses in SLE via distinct
sensors.
TLR9 senses ssDNA containing unmethylated CpG motifs.
Previous studies have revealed that TLR9 recognizes genomic
DNA from pathogens such as murine cytomegalovirus and
Herpes simplex virus type 1 or type 2 as PAMPs (Hemmi et al.,
2000; Lund et al., 2003; Krug et al., 2004a,b) (Figure 2). With
regard to the development of autoinflammatory disease, TLR9
has been also been reported to recognize self-antigens complexed
with autoantibodies. Leadbetter et al. revealed that autoreactive
B cells were activated by a chromatin-autoantibody complex in a
TLR9- and MyD88-dependent manner (Leadbetter et al., 2002).
In addition, self-DNA-containing immune complexes, which are
a well-characterized marker for SLE, were recognized by TLR9
through FcγRIIA-mediated internalization in plasmacytoid DCs
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FIGURE 1 | Autoimmune disorders may be induced by promiscuous sensing of nucleic acids.
(Means et al., 2005). Thus, immune complexes containing self-
DNAmay signal as DAMPs through TLR9, although extracellular
receptors such as FcγRIIA may be required for the delivery of
autoimmune complexes to the TLR9-localizing compartment.
As described previously, the subcellular localization of TLRs
is important for the recognition of DNA, because TLR3, 7, 8
and 9 localize to the endosomal compartment. Previous studies
identified three adaptor molecules, Unc93B1, PRAT4A, and gp96,
which are important for the trafficking of TLRs to sites for sens-
ing their ligands. Unc93B1 functions to control the trafficking of
TLRs 3, 7, and 9 from the endoplasmic reticulum (ER) to the
endosome. PRAT4A is localized in the ER and acts as a regula-
tor of the subcellular distribution of most TLRs except for TLR3.
Gp96 is a member of the heat shock protein (HSP) 90 family, and
resides in the ER where it controls the maturation of TLRs 2, 4, 5,
7, and 9 (Saitoh and Miyake, 2009). Because TLR7 and TLR9 are
regulated by the samemolecular machinery, the crosstalk between
TLR7 and TLR9 may affect the sensing of auto-nucleic acids
and the development of autoinflammatory disease. Christensen
et al. showed that a deficiency of TLR9 results in malignant
symptoms in a mouse model of lupus, despite the levels of anti-
body production specific for DNA and chromatin being down-
regulated (Christensen et al., 2005). In contrast, TLR7-deficient
mice developed attenuated lupus symptoms (Christensen et al.,
2006). In addition, a recent study revealed that TLR9 suppressed
the progression of autoinflammatory disease by antagonizing
TLR7, suggesting that TLR9 counteracts TLR7 upon the recog-
nition of self-immunocomplexes containing ssRNA or ssDNA
(Nickerson et al., 2010). To support the interaction between
TLR7 and TLR9 upon the development of autoimmune disease,
Fukui et al. generated Unc93B1D34A/D34A knock-in mice to show
that TLR9 competes with TLR7 for binding to Unc93B1 in the
healthy state, while TLR7 is constitutively activated upon autoin-
flammatory responses because TLR9 has a lower affinity for the
Unc93B1-like Unc93B1D34A/D34A mutant (Fukui et al., 2011).
RIG-I-LIKE RECEPTORS (RLRs)
Although TLRs can sense both non-self and self nucleic acids,
fibroblasts, and endothelial cells that do not express TLRs also
produce type I IFNs in response to infection with pathogens, indi-
cating the existence of other receptors that sense nucleic acids.
Yoneyama et al. determined that a cytoplasmic DExD/H box RNA
helicase, RIG-I, senses infection by RNA viruses as well as arti-
ficial dsRNA, and induces innate antiviral immune responses
mediated by type I IFNs (Yoneyama et al., 2004) (Figure 2). In
addition to RIG-I, melanoma differentiation factor-5 (MDA5)
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FIGURE 2 | Intracellular sensors for nucleic acids.
and laboratory of genetics and physiology-2 (LGP2) were also
identified; these receptors were classified as RLRs because their
protein structures were similar to that of RIG-I (Yoneyama
et al., 2005). To induce an anti-pathogen immune response, a
CARD domain in RIG-I and MDA5 transmits down-stream sig-
nals through homophilic interactions with the CARD adaptor
molecule, IFN-β promoter stimulator-1 (IPS-1, also known as
MAVS, Cardif, or VISA) (Kawai et al., 2005; Meylan et al., 2005;
Seth et al., 2005; Xu et al., 2005). The function of LGP2 is con-
troversial. Some in vitro studies showed that LGP2 negatively
regulates RIG-I- orMDA5-mediated innate immune responses by
competing for binding with their RNA ligands (Yoneyama et al.,
2005; Bamming and Horvath, 2009). However, in vivo studies
using lgp2-deficient mice revealed that LGP2 is a cofactor of RLR-
mediated innate immune signaling (Venkataraman et al., 2007;
Satoh et al., 2010).
RLRs sense pathogen-derived RNA species as PAMPs to induce
type I IFN production, while MDA5 has been detected as an
autoantigen in clinically amyopathic dermatomyositis patients
(Sato et al., 2009; Nakashima et al., 2010). Although it is
not clear how extracellular MDA5 is produced, the accumula-
tion of immunocomplexes containing MDA5 is a marker for
the frequency of rapidly progressive interstitial lung disease
(Sato et al., 2009; Nakashima et al., 2010). Accompanying these
observations, loss of function single nucleotide polymorphisms
have been found in RIG-I and IPS-1 that are closely related
to the development of autoimmune disease (Pothlichet et al.,
2011), suggesting that inhibition of RLR signaling may be impor-
tant in the progression of autoimmune disease. However, as
described earlier, excessive production of inflammatory cytokines
including type I IFNs appears to result in autoinflammatory dis-
ease. In contrast, the dysfunction of RLRs induces poor type I
IFN production, but leads to autoimmune disease (Nakashima
et al., 2010; Pothlichet et al., 2011). One possibility to explain
this phenomenon is that non-functional RLRs result in an
increased susceptibility against various types of virus infec-
tions, and the subsequent virus-mediated cell death may cause
the release of DAMPs and signaling through DAMP receptors.
Support this possibility, the loss of MDA5 function increased
the susceptibility of beta cells to viral infection with picor-
navirus or encephalomyocarditis virus-D, and resulted in type
1 diabetes, whose types of diabetes are often caused by virus
infection or autoimmunity (Colli et al., 2010; McCartney et al.,
2011). Further analyses are required to elucidate the cross-talk
between RLR signaling and the development of autoimmune
disease.
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ABSENT IN MELANOMA 2 (AIM2)-LIKE RECEPTORS (ALRs)
Although various NLR family members that can induce the acti-
vation of caspase-1 and maturation of IL-1β, IL-18, and IL-33
in response to a wide range of PAMP and DAMP molecules
have been identified, no sensor of intracellular dsDNA for IL-1β
maturation has been identified. However, four research groups
concurrently reported a role for the novel intracellular DNA
sensor, AIM2, in the activation of caspase-1 following IL-1β pro-
duction (Burckstummer et al., 2009; Fernandes-Alnemri et al.,
2009; Hornung et al., 2009; Roberts et al., 2009). AIM2 belongs
to a family of hematopoietic interferon-inducible nuclear pro-
teins with a 200-amino acid repeat (HIN-200), known as the
p200 or PYHIN family. Currently, four HIN-200 familymolecules
have been identified in humans, and six in mice. HIN-200 fam-
ily molecules share similar structural features, including a pyrin
domain at the NH2 terminus, and a HIN-200 domain at the
COOH terminus. Similar to the role of NLRP3 in IL-1β produc-
tion, AIM2 causes oligomerization of the inflammasome upon
DNA binding. The AIM2 inflammasome recruits ASC, an essen-
tial adaptor molecule, and induces NLRP3 inflammasome forma-
tion through homophilic interactions between the pyrin domain
in AIM2 and that in ASC (Figure 2). The importance of the AIM2
inflammasome upon PAMP recognition has been confirmed by
infection experiments using aim2-deficient macrophages infected
with Francisella tularensis, L. monocytogenes, vaccinia virus, her-
pes simplex virus-1 and mouse cytomegalovirus (Fernandes-
Alnemri et al., 2010; Rathinam et al., 2010).
A second ALR, interferon-inducible protein 16 (IFI16) in
humans (a homologue of p204 in mice), has been also investi-
gated as an intracellular dsDNA sensor. However, while AIM2
induces IL-1β production in response to intracellular dsDNA
binding, IFI16 is a sensor for type I IFN production upon
recognition of intracellular dsDNA (Unterholzner et al., 2010).
Although IFI16 also contains a pyrin domain, the pyrin in
IFI16 is quite distinct from that in AIM2 as it has a lower
affinity for ASC. Consistent with these different features of
pyrin, IFI16-mediated type I IFN production upon intracellular
dsDNA stimulation was not affected by ASC deficiency, sug-
gesting that the two HIN-200 family molecules regulate both
IL-1β and type I IFN production upon the recognition of intra-
cellular dsDNA (Unterholzner et al., 2010). Although AIM2-
mediated signaling appears to be distinct from IFI16-mediated
type I IFN production, recent research has revealed that IFI16
negatively regulates the AIM2-mediated activation of caspase-1
(Veeranki et al., 2011). As increased inflammatory cytokine pro-
duction is closely related to the development of autoinflam-
matory disease, the regulation between AIM2-mediated innate
immune signaling and IFI16 might be deregulated in patients
with autoimmune disease.
Roberts et al. identified p202 and AIM2 as cytosolic DNA
binding proteins in mice. p202 is another ALR molecule without
a pyrin domain, indicating an inability to bind ASC for inflam-
masome formation (Roberts et al., 2009). p202 appears to be a
negative regulator for AIM2-mediated signaling, as the reduction
of p202 results in higher AIM2-mediated activation of caspase-1
in response to intracellular DNA. However, elevated levels of
p202 have been reported to induce SLE-like symptoms in mice
(Rozzo et al., 2001). Interestingly, p202 levels are varied among
mouse species, while AIM2 is expressed at the same level, indicat-
ing that p202 expression is tightly correlated to SLE development.
Furthermore, Ravichandran et al. revealed that ablation of the
aim2 gene leads to higher expression of p202 and type I IFNs in
mice, and aim2-deficient mice are prone to SLE (Panchanathan
et al., 2010). Taken together, these findings suggest that mouse
p202 might be homologous to human IFI16. In support of this,
expression levels of IFI16 and anti-IFI16 autoantibodies were
dramatically increased in SLE patients, indicating that IFI16 has
similar features to p202 (Mondini et al., 2006).
A recent article described a correlation between psoriasis
symptoms and AIM2 activation. Psoriasis is a chronic autoin-
flammatory disease caused by increased IL-1β production leading
to Th17 cell maturation (Ghoreschi et al., 2010). Dombrowski
et al. observed increased levels of cytosolic DNA fragments in
skin lesions from psoriatic patients, which could be sensed by
AIM2 (Dombrowski et al., 2011). Interestingly, those DNA frag-
ments, which might be released from skin lesions in psoriatic
patients, were internalized through binding to the antimicrobial
peptide LL-37 (Dombrowski et al., 2011). Previous studies have
shown that the complex of self-DNAwith LL-37 can activate plas-
macytoid DCs to produce type I IFNs, and complex-mediated
type I IFN production is closely related with skin lesion devel-
opment in psoriasis (Nestle et al., 2005; Lande et al., 2007). AIM2
is an interferon-inducible gene, suggesting that LL-37 complexes
with self-DNA activate plasmacytoid DCs to produce type I IFNs,
and that the subsequent upregulation of AIM2 leads to IL-1β
production, and finally, psoriatic skin lesions occur because of
the increased levels of type I IFN production as well as IL-1β
production.
HIGH MOBILITY GROUP BOX 1 (HMGB1)
HMGB1 has been reported to be a major DAMP molecule.
Goodwin et al. first identified HMGB1 from calf thymus chro-
matin as a non-histone DNA-binding protein (Goodwin et al.,
1973). However, Wang et al. showed that amouse macrophage cell
line released HMGB1 in response to LPS stimulation. In addition,
LPS-treated mice developed increased serum levels of HMGB1,
similar to human patients with sepsis, suggesting that HMGB1 is a
DAMPmolecule in regard to sepsis symptoms (Wang et al., 1999).
Accumulating evidence suggests that cellular injury results in
the release of HMGB1 leading to inflammation (Abraham et al.,
2000; Scaffidi et al., 2002). Consistent with these observations,
numerous studies have showed a correlation between HMGB1
and autoimmune/inflammatory diseases such as atherosclero-
sis, diabetes, SLE, rheumatoid arthritis and Sjögren syndrome
(Taniguchi et al., 2003; Porto et al., 2006; Urbonaviciute et al.,
2008; Devaraj et al., 2009).
As described previously, higher serum levels of immunocom-
plexes of self-DNA with autoantibodies is a hallmark of SLE.
Previous research has shown that HMGB1 is also contained in
immunocomplexes and can elicit inflammatory cytokine produc-
tion, suggesting that HMGB1 may be a carrier of DNA DAMPs
(Tian et al., 2007; Urbonaviciute et al., 2008). Furthermore,
HMGB1 appears to promiscuously bind numerous molecules
such as LPS, IFN-γ, IL-1β, and CXCL12 to induce synergistic
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physiological responses (Sha et al., 2008; Youn et al., 2008;
Campana et al., 2009). Moreover, HMGB1 can sense pathogen-
derived nucleic acids, which induce type I IFN production (Yanai
et al., 2009). Collectively, HMGB1 might be a promiscuous
carrier that enhances innate immune responses against PAMPs
and DAMPs.
The receptors for HMGB1 have been investigated, but are
still controversial. A well-studied receptor for HMGB1 is the
receptor for advanced glycation end products (RAGE). Similar
to HMGB1, RAGE is a promiscuous receptor that can bind to
various ligands including DNA, RNA, SAA protein, HSPs and
prion protein, suggesting that RAGEmay sense a variety of DAMP
molecules in an HMGB1-dependent or -independent manner
(Sims et al., 2010). Experiments with rage-deficient mice revealed
that HMGB1-mediated DNA sensing requires RAGE for inter-
nalization of DNA complexes to produce type I IFNs via TLR9
(Tian et al., 2007). Interestingly, RAGE could associate with
TLR9 upon recognition of the A type of CpG-HMGB1 complex,
indicating a possible function for RAGE as a bridge molecule
between the extracellular HMGB1-DNA complex and the TLR9
compartment (Tian et al., 2007). In contrast to this observa-
tion, nucleosomes could sense HMGB1 complexes independently
of RAGE. Instead of RAGE, TLR2 appears to be important for
the recognition of HMGB1-nucleosome complexes, suggesting
that the sensing machinery of the HMGB1-nucleosome com-
plex might be distinct from that of the HMGB1-DNA complex,
as the HMGB1-nucleosome complex could not elicit produc-
tion of type I IFNs even though TNF-α or IL-10 were induced
(Urbonaviciute et al., 2008). Furthermore, recent research identi-
fied a novel ligand for RAGE, complement C3a, that binds human
stimulatory CpG DNA to induce type I IFNs in an HMGB1-
independent manner. This suggests that RAGE-mediated DNA
sensing may involve numerous ligands (Ruan et al., 2010).
Although there are many varieties of HMGB1- or RAGE-
mediated DNA recognition, both molecules are strongly associ-
ated with the induction of inflammation and the development of
chronic inflammatory disease.
DNA-DEPENDENT ACTIVATOR OF IFN-REGULATORY FACTORS (DAI)
DAI has been identified as a molecule that recognizes intra-
cellular DNA. Previous studies have revealed that DAI senses
Z-type DNA; however, it may also bind to B-type DNA and
induce type I IFN production through associations with TBK1
and IRF3 (Takaoka et al., 2007). Interestingly, DAI-deficient mice
responded normally to cytosolic dsDNA stimulation, suggesting
that DAI may function as one of a number of DNA sensors in a
cell type-specific fashion (Ishii et al., 2008). Currently, the func-
tion of DAI is controversial, although the genetic adjuvanticity of
DAI has been shown to induce strong cytotoxic T cell responses
(Lladser et al., 2011). Although the ability of DAI to recognize
DNA DAMPs has not been determined yet, DAI might be a link
between the development of autoimmune disease and host DNA
immune complexes.
HISTONES
Histone H2B (H2B) is a component of chromatin, and Kobiyama
et al. identified that H2B also functions to sense intracellular
dsDNA. Previous reports showed that histones act as DAMPs, and
that excessive intracellular dsDNA induces type I IFNs through
H2B (Kobiyama et al., 2010). In confirmation of this, H1 or H2
are released from the nucleus after DNA damage, and are translo-
cated to mitochondria following the induction of apoptosis. In
addition, H1, H2A, and H2B may act as antimicrobial proteins
in certain animals, suggesting that H2B is an intracellular dsDNA
sensor that recognizes dsDNA PAMPs and DAMPs (Kawashima
et al., 2011). Histones may be related to autoimmune diseases
as anti-histone antibodies were detected in patients with such
diseases. Further analyses are required to clarify the relationship
between histones and autoimmune disease.
Ku70
Ku70 functions in DNA repair, V(D)J recombination and in
retaining the telomere. Zhang et al. showed that various DNA
species-induced the production of type III interferon, IFN-λ1,
and identified Ku70 as a novel DNA sensor by pull-down assay
from the nucleus compartment (Zhang et al., 2011a). While
other DNA sensors are important for the production of type I
IFNs, Ku70 appears to be important for type III IFN production
through IRF1 and IRF7. Furthermore, Ku70-mediated type III
IFN production is restricted when the length of intracellular DNA
stimuli is greater than 500 base pairs.
RNA POLYMERASE III
As described above, RIG-I senses intracellular RNA species, but
may also recognize intracellular dsDNA. siRNA treatment of a
human hepatoma cell line, Huh7, suppressed dsDNA-mediated
type I IFN production. Subsequently, Chiu et al. showed that
RIG-I senses the transcribed RNA byproducts of DNA templates
that are generated by RNA polymerase III (as is the case for
poly(dA·dT)·poly(dT·dA) and EBV genomic DNA) and induces
production of type I IFNs (Chiu et al., 2009). An inhibitor of
RNA polymerase III suppressed DNA-mediated type I IFN pro-
duction, suggesting that RNA polymerase III is a distinct DNA
sensor. However, RNA polymerase III-mediated dsDNA sensing
is restricted to sequences of DNA stimuli containing less dA·dT
than dG·dC.
DHX9 AND DHX36
Although the DExD/H box RNA helicase family contains RIG-I
and MDA5, which function as RNA sensors, recent reports have
revealed a similar RNA helicase family of molecules (DExDc fam-
ily) that contain DHX9 and DHX36, which function as ssDNA
sensors in plasmacytoid DCs (Kim et al., 2010). Interestingly,
while DHX36 senses CpG-A, DHX9 senses CpG-B in a MyD88-
dependent manner. This may suggest that ssDNA PAMPs or
DAMPs are recognized by either DHX9 or DHX36, but recent
research has shown that DHX9 collaborates with IPS-1 to recog-
nize dsRNA in myeloid DCs, indicating the promiscuous sensing
of DHX9 (Zhang et al., 2011b).
LEUCINE-RICH REPEAT FLIGHTLESS-INTERACTING PROTEIN 1 (Lrrfip1)
Some sensor molecules such as TLRs or NLRs share common
molecular patterns, such as leucine rich repeats (LRRs), which are
important for ligand recognition or protein–protein interactions.
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An LRR-containing molecule, Lrrfip1, has been reported to sense
intracellular DNA or RNA (Yang et al., 2010). Interestingly,
whereas other DNA sensors often regulate type I IFN-related
transcription factors such as IRF3/7 or caspase-1 to induce mat-
uration of IL-1β, Lrrfip1 stimulates β-catenin and CBP/p300 to
enhance ifnb1 transcription, indicating a novel pathway involving
β-catenin for type I IFN production upon cytosolic DNA sensing.
Because Wnt/β-catenin signaling is also linked to tumor devel-
opment, further analyses may identify the machinery involved in
the regulation of type I IFN signaling by Lrrfip1 under tumor
development.
STING (STIMULATOR OF INTERFERON GENES PROTEIN)
The major function of MHC class II is antigen presentation,
while monoclonal antibodies against MHC class II can cause cell
activation or apoptotic cell death. Jin et al. identified a novel
tetraspanin family molecule, MPYS, associated with MHC-II-
mediated cell death (Jin et al., 2008). Three research groups
performing cDNA library screening to identify molecules asso-
ciated with activation of the type I IFN promoter identified the
same molecule, STING (also known as MITA, and ERIS). STING
is a novel adaptor molecule that activates innate immune signal-
ing mediated by intracellular nucleic acid stimuli (Ishikawa and
Barber, 2008; Zhong et al., 2008; Sun et al., 2009). Surprisingly,
the Barber research group further revealed that STING is essen-
tial for the induction of type I IFN production following sensing
of cytosolic dsDNA, using STING-deficient mice. Based on their
imaging analysis, STING appears to localize to the ER during the
steady state, but translocates to the Golgi apparatus upon intra-
cellular dsDNA stimulation to activate down-stream molecules
such as TBK1. This suggests that STING is an essential adaptor
molecule for cytosolic dsDNA-mediated type I IFN production
in mice.
Cyclic-di-GMP and c-di-AMP are small molecules that func-
tion as second messengers and are important for cell survival, dif-
ferentiation, colonization, and biofilm formation. Recent research
has revealed that the cytosolic delivery of c-di-GMP or c-di-
AMP-induced type I interferon (IFN) production from bone
marrow macrophages, suggesting that c-di-GMP and c-di-AMP
are bacterial PAMPmolecules (McWhirter et al., 2009; Woodward
et al., 2010). As type I IFN production by c-di-GMP or c-di-
AMP requires their internalization, live invasive bacteria possibly
produce these second messenger molecules after internalization
into cells.
Recent reports have revealed that STING is a direct sensor of
bacterial second messenger molecules, such as c-di-GMP or c-di-
AMP (Burdette et al., 2011; Jin et al., 2011). This indicates the
novel possibility that cytosolic dsDNA stimulation might produce
c-di-GMP/c-di-AMP or related molecules that can be sensed by
STING and induce type I IFN production.
ADJUVANTICITY THROUGH DNA DAMPs
Although DNA DAMPs are closely associated with the devel-
opment of autoimmune disease, DNA DAMPs also contribute
to the activation of acquired immune responses following vac-
cination with alum adjuvant. Previous studies have shown that
genomic DNA from dying cells induces the maturation of
antigen-presenting cells as well as antigen-specific antibody and
cytotoxic T cell responses. This suggests that self-DNA DAMPs
can activate innate immune responses that induce acquired
immunoresponses. Recently, Marichal et al. demonstrated that
the adjuvanticity of alum was dependent on self-DNA released
from cells at the alum inoculation site (Marichal et al., 2011).
NLRP3 appears to be a key sensor in the induction of alum-
mediated innate immunity, although its function is only partially
dependent upon alum adjuvanticity. Intraperitoneal inocula-
tion of mice with alum induced the recruitment of neutrophils,
and the resulting alum deposits contained high amounts of
genomic DNA. Because treatment with DNase I attenuated alum
adjuvanticity, the alum-mediated release of genomic DNA may
account for its potent adjuvanticity. In addition, the alum-
mediated induction of antibody production is dependent on
TBK1 and IRF3 as demonstrated using knockout mice, suggest-
ing that alum-mediated genomic DNA induces high adjuvantic-
ity of alum via the TBK1/IRF3 pathway, while alum-mediated
uric acid production is less related to alum adjuvanticity via
NLRP3 (Marichal et al., 2011). Furthermore, self-DNAs from
alum inoculation can activate inflammatory monocytes, and
homodimers of IL-12p40 are more important than type I IFN
production upon alum adjuvanticity. Taken together, these find-
ings suggest that self-DNA DAMPs are important for pathogen
elimination, the development of autoimmune disease and the
adjuvanticity of alum. Further analyses are required to elu-
cidate which types of cells produce self-genomic DNA after
adjuvant inoculation, and which sensors recognize extracellular
genomic DNAs.
In addition to alum adjuvant, there are many licensed adju-
vants such as MF59®, AS03®, and AS04®. Both MF59® and
AS03® are emulsions of oil/water containing squalene. Although
both adjuvants elicit antibody responses as well as cell-mediated
immune responses specific for antigens, their mode of action has
not been identified. Information on the receptors for and signal-
ing induced by these adjuvants is needed, because unfortunate
side effects can be expected more easily.
CONCLUDING REMARKS
Many sorts of nucleic acid species exist in the environ-
ment. These species affect all organisms such as the evolu-
tion of organisms, the inflammatory response, and the advent
of drug-resistant microorganisms. To prevent pathogen infec-
tion, mammalian cells have equipped themselves with many
sorts of sensors to recognize exogenous nucleic acid species as
PAMPs, while those sensors are also stimulated by endogenous
nucleic acids species as DAMPs. Dysfunction of the machiner-
ies sensing both PAMPs and DAMPs is strongly associated
with chronic inflammatory disease or autoimmunity. In addi-
tion, both PAMPs and DAMPs underlie the action of vaccines,
because most modern vaccines contain adjuvants, which are
composed of both PAMP- and DAMP-associated molecules.
Therefore, the machinery responsible for sensing nucleic acids
species should be further elucidated to help us understand
machinery of chronic infection, autoimmune development, iden-
tifying the side effects of vaccines, and developing safe vaccine
adjuvants.
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